Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ionomycin calcium is a narrow-spectrum polyether antibiotic isolated from *Streptomyces conglobatus* that acts as a potent and selective calcium ionophore. It binds divalent cations, particularly calcium ($Ca^{2+}$), with high specificity and transports them across biological membranes, thereby increasing intracellular calcium levels. In laboratory research, it is widely used as a tool to study calcium transport, calibrate fluorescent calcium indicators, and stimulate T-cell activation (often in combination with phorbol 12-myristate 13-acetate). In clinical and reproductive medicine, ionomycin calcium is utilized in artificial oocyte activation (AOA) protocols during intracytoplasmic sperm injection (ICSI) to improve fertilization rates and embryo quality in patients experiencing fertilization failure or severe male factor infertility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ionomycin calcium.